Elusys Overview
Leadership
Biodefense
Executive Team
Board of Directors
Technology
Heteropolymer Antibodies
CR1 Vaccines
Publications
Overview
Process Animation
Antibody Heteropolymers
Antigen Heteropolymers
Anthrax Antibody
Pipeline
Anthim Anthrax Antibody
Staph A HP - ETI-211
Candida HP
CR1 Vaccines
Press Releases
Presentations
Our Values
Working at Elusys
Open Positions
Benefits
Location
NEWS & EVENTS
PRESS RELEASES 2009
2009
2008
2007
2006
2005
2004
June 16th, 2009
Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement